Seborrheic keratosis is a benign growth of immature keratinocytes. The name is essentially a historical misnomer; Although the lesions of seborrheic keratosis appear greasy, they are not caused by sebum.

Epidemiology


Seborrheic keratosis is the most common benign skin tumor in adults > 30 years of age.

Etiology


  • Associated with activating mutations of the fibroblast growth factor receptor 3.
  • SK itself is benign, but rapid onset of numerous SKs (Leser-Trélat sign) is often associated with an internal malignancy (eg, gastric adenocarcinoma), possibly due to overproduction of insulin-like growth factor 1 and other cytokines.

Tip

Pathophysiology


Clinical features


  • Appearance: Well-circumscribed, round or oval macules, papules, or plaques.
  • Classic Description: Dull, waxy, verrucous, velvety, or crumbly surface with a distinct “stuck-on” appearance. c
  • Color: Highly variable; flesh-colored, tan, brown, to deeply pigmented/black.
  • Distribution: Trunk, face, neck, and extremities (spares palms and soles).
  • Symptoms: Typically asymptomatic; can become irritated, pruritic, or bleed with minor friction/trauma.

Diagnostics

  • Initial/Screening: Clinical diagnosis based on gross visual inspection and dermoscopy.
    • Dermoscopy findings: Milia-like cysts, comedo-like openings, and “brain-like” (cerebriform) pattern.
  • Confirmatory/Gold Standard: Excisional or shave biopsy (only indicated if lesion is atypical, changing, bleeding, or cannot be distinguished from melanoma).
    • Histology: Hyperkeratosis, papillomatosis, acanthosis, and intraepidermal pseudo-horn cysts (keratin-filled invaginations).
  • Key Labs/Imaging:
    • None required for isolated, typical SKs.
    • If suspected Leser-Trélat sign: Age-appropriate cancer screening, GI endoscopy (EGD/colonoscopy), and CT chest/abdomen/pelvis.

Treatment

  • First-line: Observation & reassurance (benign lesion with no malignant potential).
  • Second-line (Symptomatic / Cosmesis / Patient preference):
    • Cryotherapy (liquid nitrogen spray): Fast, effective, standard office procedure.
    • Curettage / Shave excision / Electrodessication: Useful when histopathologic confirmation is desired.
    • Topical hydrogen peroxide 40% solution (FDA-approved, alternative non-surgical option).
  • Refractory / Suspicious Lesions:
    • Complete shave or punch biopsy to rule out malignancy.
  • Leser-Trélat Presentation:
    • Treat the primary underlying internal malignancy (SKs often regress following resection/systemic therapy).